Artiva Biotherapeutics, Inc. (ARTV) NASDAQ
5.45
+0.44(+8.78%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
5.45
+0.44(+8.78%)
Currency In USD
| Market Cap | 104.87M |
| Enterprise Value | 89.11M |
| P/E Ratio | -1.59 |
| PEG Ratio | 1.8 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.21 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -1.38 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.64 |
| Return On Equity | -0.6 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -2.6M |
| EBITDA | -88.01M |
| Net Income | -83.87M |
| Diluted EPS | -3.43 |
| Total Cash | 108.01M |
| Total Cash/Share | 4.42 |
| Total Debt | 10.94M |
| Total Debt/Equity | 0.1 |
| Current Ratio | 8.61 |
| Book Value Per Share | 4.5 |
| 52-Week Change | 81.67 |
| 52-Week High | 7.75 |
| 52-Week Low | 1.47 |
| Moving Average 50 Days | 4.96 |
| Moving Average 200 Days | 3.6 |
| Average Volume | 182,332 |
| Shares Outstanding | 24.72M |
| % Held by Institutions | 69.26 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |